621PDPhase II trial of tepotinib vs sorafenib in Asian patients (pts) with advanced hepatocellular carcinoma (HCC). (23rd October 2018) - Ryoo, B-Y; Ren, Z; Kim, T-Y; Pan, H; Rau, K-M; Choi, H J; Park, J-W; Kim, J H; Yen, C-J; Kim, B-H; Zhou, D; Straub, J; et al.